Conduite à tenir devant un nodule thyroïdien isolé ou au sein d’un goître multi- hétéro-nodulaire. Quand on ne dispose pas de scintigraphie thyroïdienne (Tahiti) . CAT DEVANT UN NODULE THYROIDIEN PowerPoint Presentation, PPT – DocSlides- A. HMRUC. Le nodule. thyroïdien est très fréquent. Le cancer. an isolated thyroid nodule] Conduite à tenir devant un nodule thyroïdien isolé. Le nodule thyroïdien constitue la pathologie la plus fréquente des thyroïdies.

Author: Zuzuru Garg
Country: Estonia
Language: English (Spanish)
Genre: Automotive
Published (Last): 18 January 2005
Pages: 201
PDF File Size: 2.60 Mb
ePub File Size: 19.10 Mb
ISBN: 201-1-73628-779-9
Downloads: 36333
Price: Free* [*Free Regsitration Required]
Uploader: Kazrajar

Eur J Gastroenterol Hepatol. New treatment strategies in advanced neuroendocrine tumours. Options Irinotecan-cisplatine [Nakano ] niveau de la recommandation: A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas. N Engl J Med ; Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.

Prognostic factors influencing survival from metastatic stage Thyrodiien gastroenteropancreatic well-differentiated endocrine carcinoma.

Endoc – Online Flashcards by Ilo Raza | Brainscape

Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: Best Pract Res Clin Gastroenterol.


Comment citer ce chapitre?

The journal is also open to contributions focusing on functional and metabolic imaging carried out with methods other than nuclear medicine. Phase III jn of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: Examens morphologiques initiaux Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome RADIANT Antonodimitrakis P et al.

11. Tumeurs neuroendocrines digestives (Dernière mise à jour le 12/10/2017)

Prospective, randomized, multicenter trial on uh antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors–the International Lanreotide and Interferon Alfa Study Group.

WHO classification of neoplasms of the neuroendocrine pancreas. Once production of your article has started, you can track the status of your article via Track Your Accepted Article.

Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: Most Cited Articles The most cited articles published sinceextracted from Scopus. Therapeutic effect of noxule malate and its influence on blood glucose concentrations in a patient with metastatic insulinoma.


Nodule thyroïdien.

Treatment of poorly differentiated neuroendocrine jodule with etoposide and cisplatin. TNE de primitif inconnu. If you do not already have an account you will need to register here.

Your Research Data Share your research data Visualize your data. Submit Your Paper Enter your login details below.

Chimioembolisation [Zappa ] Contre-indications: First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.

Int J Biol Markers. Somatuline LP 60, 90 et mg: Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. This free service is available to anyone who has published and whose publication is in Scopus. WHO classification of tumours of endocrine organs.